|
2022
|
Invention
|
Methods of treating neurofibromatosis type 1 with n-((r))-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2... |
|
2021
|
Invention
|
Methods of treating neurofibromatosis with n-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-... |
|
|
Invention
|
Compositions of essentially pure form iv of n-((r)-2,3- dihydroxypropoxy)-3,4-difluoro-2- (2-fluo... |
|
|
Invention
|
Compositions of essentially pure form iv of n-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro... |
|
2020
|
P/S
|
Pharmaceutical preparations for the treatment of cancer |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer |
|
2019
|
Invention
|
Antibodies to m-csf.
The present invention relates to antibodies and antigen-binding portions th... |
|
2018
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of psychiatric diseases, degenerativ... |
|
|
Invention
|
2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones. The present invention provides substituted 2... |
|
2017
|
Invention
|
Antibodies to m-csf. The present invention relates to antibodies and antigen-binding portions the... |
|
|
Invention
|
Solid pharmaceutical compositions containing pregabalin.
A solid pharmaceutical composition cont... |
|
2013
|
Invention
|
Calcium dicarboxylate ethers.
The invention is a pharmaceutical composition comprising a carboxy... |
|
|
Invention
|
4-phenylamino-quinazolin-6-yl-amides. This invention provides quinazoline compounds of the formul... |
|
2011
|
Invention
|
Pharmaceutical compositions of amorphous atorvasta and process for preparing same.
Solid pharmac... |
|
2010
|
Invention
|
Nucleic acid molecules encoding antibodies to m-csf. The present invention relates to antibodies ... |
|
|
Invention
|
Methods of treating osteoarthritis with il-6 antagonists.
The present invention provides for met... |
|
2008
|
P/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic ... |
|
|
Invention
|
Therapeutic pyrazolo[3,4-b]pyridines and indazoles.
The present invention provides for compounds... |
|
|
Invention
|
Inhibitors of factor xa and other serine proteases involved in the coagulation cascade.
Compound... |
|
2007
|
Invention
|
Statin-carboxyalkylether combinations. The invention is a pharmaceutical composition comprising a... |
|
|
Invention
|
Methods of treating arthritic conditions with antibodies to m-csf. The present invention relates ... |
|
|
Invention
|
Pharmaceutical uses for alpha2delta ligands.
The invention relates to a method of treating cent... |
|
|
Invention
|
[r-(r*r*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl-3-phenyl-4-[(phenylamino)carbonyl]-1... |
|
2006
|
P/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes. |
|
|
Invention
|
Amino acids with affinity for the α2δ-protein. Certain β-amino acids that bind to the alpha-2-del... |
|
|
Invention
|
Hetero biaryl derivatives as matrix metalloproteinase inhibitors.
This invention provides compou... |
|
|
Invention
|
Novel forms of ⏧r-(r*,r*)]-2-(4-fluorophenyl)-b,b-dihydroxy-5-(1-methylethyl)-3-phenyl-4-⏧(p... |
|
|
Invention
|
Androgen modulators. The present invention is directed to a new class of benzonitriles and to the... |
|
|
Invention
|
Novel imidazoles.
Novel imidazole compounds and pharmaceutical compositions are described, as ar... |
|
|
Invention
|
Inhibitors of colony stimulating factors.
A hematopoetic factor called “colony stimulating facto... |
|
|
Invention
|
Process for producing ethers.
The invention is directed to a process for producing the compound ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system d... |
|
2005
|
Invention
|
Androgen modulators.
The present invention is directed to a new class of benzonitriles and to th... |
|
|
Invention
|
Androgen modulators.
The present invention is directed to the discovery of a new class of androg... |
|
|
Invention
|
Androgen modulators.
The present invention is directed to the compound 4-(2-methoxy-phenoxy)-2-t... |
|
|
Invention
|
Combination of atomoxetine and a 5ht1a receptor agonist for treating adhd and other disorders.
T... |
|
|
Invention
|
Pyrrolyl substituted pyrido[2,3-d]pyrimidin-7-ones and derivatives thereof as therapeutic agents.... |
|
|
Invention
|
Imidazole-based hmg-coa reductase inhibitors.
The present invention relates to methods of treati... |
|
2004
|
Invention
|
Antibacterial agents.
Compounds of formula I and methods for their preparation are disclosed. Fu... |
|
|
Invention
|
Pyrimidines as inhibitors of phosphoinositide-3-kinases (pi3k).
The present invention provides p... |
|
|
Invention
|
Crystalline forms of [r-(r* ,r*)]-2-(4-fluorophenyl)-beta, -dihydroxy-5-(1-methylethyl)-3-phenyl-... |
|
2001
|
P/S
|
Hemorrhoidal preparations. |
|
2000
|
Invention
|
Stabilized pharmaceutical preparation of gamma-aminobutyric acid derivatives and process for prep... |
|
1998
|
P/S
|
Pharmaceutical preparation for the treatment of Coronary disease |
|
|
Invention
|
Isobutylgaba and its derivatives for the treatment of pain. The instant invention is a method of ... |
|
1996
|
P/S
|
Pharmaceutical preparations, namely preparations for reducing lipids. |
|
|
P/S
|
Pharmaceutical preparations, namely analgesics. |
|
|
P/S
|
Pharmaceutical preparations, namely preparations for the heart and circulation. |
|
|
P/S
|
anticonvulsants |
|
1988
|
P/S
|
CORONARY PREPARATIONS |
|
1982
|
P/S
|
Antibiotic drug for treatment of infectious diseases and allied conditions. |
|
1976
|
P/S
|
Pharmaceutical preparation, namely a hypolipidemic. |
|
1968
|
P/S
|
Pharmaceutical formulations of profadol hydrochloride. |
|
1959
|
P/S
|
Anticonvulsant Preparation |
|
|
P/S
|
Psychic Energizer |
|
1956
|
P/S
|
ANTICONVULSANT PREPARATION |
